These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Efficacy of linezolid versus comparator therapies in Gram-positive infections. Wilcox MH J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140 [TBL] [Abstract][Full Text] [Related]
27. Control of multiply resistant cocci: do international comparisons help? Harbarth S; Albrich W; Goldmann DA; Huebner J Lancet Infect Dis; 2001 Nov; 1(4):251-61. PubMed ID: 11871512 [TBL] [Abstract][Full Text] [Related]
28. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece. Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Salem-Bekhit MM; Moussa IM; Muharram MM; Alanazy FK; Hefni HM Indian J Med Microbiol; 2012; 30(1):44-51. PubMed ID: 22361760 [TBL] [Abstract][Full Text] [Related]
31. An overview of antimicrobial susceptibility patterns of gram-positive bacteria from National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. Mootsikapun P; Trakulsomboon S; Sawanpanyalert P; Aswapokee N; Suankratay C J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S87-90. PubMed ID: 21294504 [TBL] [Abstract][Full Text] [Related]
32. Emerging resistance in clinically important gram-positive cocci. Thornsberry C West J Med; 1996 Jan; 164(1):28-32. PubMed ID: 8779198 [TBL] [Abstract][Full Text] [Related]
33. Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci. Tsao SM; Lin HC; Lee CM; Hsu GJ; Chen CM; Sun W; Liu YC; Jang TN; Cheng YJ; Lu PL; Chiang PC; Wang LS; Kung HC; Chuang YC; Shi ZY; Liu JW; Huang CH; Lu CT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S184-7. PubMed ID: 19013352 [TBL] [Abstract][Full Text] [Related]
34. [Interpretive reading of the antibiogram in gram positive cocci]. Torres C; Cercenado E Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):541-53. PubMed ID: 20400208 [TBL] [Abstract][Full Text] [Related]
36. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea. Hwang SH; Kim MN; Pai CH; Huh DH; Shin WS Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615 [TBL] [Abstract][Full Text] [Related]
37. Rapid multiplex detection of the resistance genes Shanmugakani RK; Fujiya Y; Akeda Y; Hamaguchi S; Hamada S; Tomono K J Med Microbiol; 2020 Feb; 69(2):249-255. PubMed ID: 32003712 [No Abstract] [Full Text] [Related]
38. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital. Gebreselassie S Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573 [TBL] [Abstract][Full Text] [Related]
39. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection]. Yang QW; Wang H; Sun HL; Xu YC; Xie XL; Chen MJ Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):220-4. PubMed ID: 19576091 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]